Back
Allogene Therapeutics Quote, Financials, Valuation and Earnings
Invest. Do Good. Get Rewarded. Just $0.25/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
11
ALLO
Allogene Therapeutics
Last Price:
2.10
Seasonality Move:
6.59%
7 Day Trial
ALL ACCESS PASS
$
7
Start Investing Smarter Unlock Louis Navellier's Stock Grader for free
Louis' clients have paid up to $30,000 for these insights - now you can try it at no cost.Allogene Therapeutics Price Quote
$2.10
+0.05 (+2.44%)
(Updated: November 21, 2024 at 2:15 PM ET)
Allogene Therapeutics Key Stats
Sell
11
Allogene Therapeutics (ALLO)
is a Sell
Day range:
$1.99 - $2.14
52-week range:
$2.01 - $5.78
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
4,552.12
P/B ratio:
0.97%
Volume:
2.4M
Avg. volume:
2.3M
1-year change:
-31.44%
Market cap:
$450.8M
Revenue:
$95K
EPS:
$-1.56
How Much Does Allogene Therapeutics Make?
Data Unavailable
Is Allogene Therapeutics Growing As A Company?
Data Unavailable
Allogene Therapeutics Stock Price Performance
-
Did Allogene Therapeutics Stock Go Up Last Month?
Allogene Therapeutics share price went down by -27.82% last month -
Did ALLO's Share Price Rise Over The Last Year?
ALLO share price fell by -31.44% over the past 1 year
What Is Allogene Therapeutics 52-Week High & Low?
-
What Is Allogene Therapeutics’s 52-Week High Share Price?
Allogene Therapeutics has traded as high as $5.78 over the past 52 weeks -
What Is Allogene Therapeutics’s 52-Week Low Share Price?
Allogene Therapeutics has traded as low as $2.01 over the past 52 weeks
Allogene Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Allogene Therapeutics?
-
How Much Debt Does Allogene Therapeutics Have?
Total long term debt quarterly is $0 -
How Much Cash Does Allogene Therapeutics Have?
Cash and short term investments quarterly total is $291.6M -
What Is Allogene Therapeutics’s Book Value Per Share?
Book value per share is 2.21
Is Allogene Therapeutics Cash Flow Positive?
-
What Is ALLO Cash Flow From Operations?
Cash flow from operations (TTM) is -$217.3M -
What Is Allogene Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $111.1M -
What Is Allogene Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is $88.2M
Allogene Therapeutics Return On Invested Capital
Data Unavailable
Allogene Therapeutics Earnings Date & Stock Price
-
What Is Allogene Therapeutics's Stock Price Today?
A single share of ALLO can be purchased today for 2.05 -
What Is Allogene Therapeutics’s Stock Symbol?
Allogene Therapeutics trades on the nasdaq under the ticker symbol: ALLO -
When Is Allogene Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Allogene Therapeutics is scheduled on March 14, 2025 -
When Is ALLO's next ex-dividend date?
Allogene Therapeutics's next ex-dividend date is November 21, 2024 -
How To Buy Allogene Therapeutics Stock?
You can buy Allogene Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Allogene Therapeutics Competitors
-
Who Are Allogene Therapeutics's Competitors?
Below is a list of companies who compete with Allogene Therapeutics or are related in some way:
Allogene Therapeutics Dividend Yield
-
What Is ALLO Dividend Yield?
Allogene Therapeutics’s dividend yield currently is 0% -
What Is Allogene Therapeutics’s Payout Ratio?
Allogene Therapeutics’s payout ratio is 0% -
When Did Allogene Therapeutics Last Pay A Dividend?
The latest dividend pay date is November 21, 2024 -
What Is Allogene Therapeutics’s Dividend Per Share?
Allogene Therapeutics pays a dividend of $0.00 per share
Allogene Therapeutics Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 17.77% |
| Revenue: | 0% | -100% |
Analyst Recommendations
| Buy Recommendations: | 9 |
|---|---|
| Hold Recommendations: | 5 |
| Sell Recommendations: | 0 |
| Price Target: | 9.08 |
| Upside from Last Price: | 343.09% |